Choroidal neovascularisation in children

British Journal of Ophthalmology

Volumn 92, Issue 4, 2008, Pages 451-454

  Sivaprasad, S ^a   Moore, A T ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN ANTIBODY;

EYE SURGERY; HUMAN; INFLAMMATION; INTRAOCULAR PRESSURE; LASER COAGULATION; OPTIC NERVE; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA DYSTROPHY; REVIEW; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

CHILD; CHOROIDAL NEOVASCULARIZATION; EYE INFECTIONS; HUMANS; LASER COAGULATION; OPTIC NERVE DISEASES; PHOTOCHEMOTHERAPY;

EID: 41849148275     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.124586     Document Type: Review

References (55)

1. Spaide RF. Choroidal neovascularization in younger patients Curr Opin Ophthalmol 1999;10:177-81
2. Cohen SY, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103: 1241-43.
3. Wilson ME, Mazur DO. Choroidal neovascularization in children: report of five cases and literature review. J Pediatr Ophthalmol Strabismus 1988;25:23-9.
4. Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol 2005;16:364-8.
5. Gutman FA. The natural course of active choroidal lesions in the presumed ocular histoplasmosis syndrome. Trans Am Ophthalmol Soc 1979;77:515-41.
6. Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology 1984;91:1592-602.
7. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol 2004;48:386-91.
8. Fine SL, Owens SL, Heller JA, et al. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol 1981;91:318-22.
9. Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, et al. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 2006;26:396-403.
10. Augsburger JJ, Benson WE. Subretinal neovascularization in chronic uveitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980;215:43-51.
11. Hirano K, Tanikawa A, Miyake Y. Neovascular maculopathy associated with rubella retinopathy. Jpn J Ophthalmol 2000;44:697.
12. Gass JDM. In: Stereoscopic atlas of macular diseases. St Louis: Mosby, 1997:118-23.
13. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606.
14. Gass JDM. Choroidal neovascular membranes: their visualisation and treatment. Trans Am Acad Ophthalmol Otolaryngol 1973;77:310-20.
15. Hoover DL, Robb RM, Petersen RA. Optic disc drusen in children. J Pediatr Ophthalmol Strabismus 1988;25:191-5.
16. Yedavally S, Frank RN. Peripapillary subretinal neovascularization associated with coloboma of the optic nerve. Arch Ophthalmol 1993;111:552-3.
17. Borodic GE, Gragoudas ES, Edward WO, et al. Peripapillary subretinal neovascularization and serous macular detachment. Association with congenital optic nerve pits. Arch Ophthalmol 1984;102:229-31.
18. Chuman H, Nao-i N, Sawada A. A case of morning glory syndrome associated with contractile movement of the optic disc and subretinal neovascularization. Nippon Ganka Gakkai Zasshi 1996;100:705-9.
19. Nguyen C, Borruat FX. Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases. Klin Monatsbl Augenheilkd 2005;222:275-8.
20. Browning AC, Mengher LS, Gregson RM, et al. Visual outcome of malignant hypertension in young people. Arch Dis Child 2001;85:401-3.
21. Raman SV, Desai UR, Anderson S, et al. Visual prognosis in patients with traumatic choroidal rupture. Can J Ophthalmol 2004;39:260-6.
22. Wood CM, Richardson J. Chorioretinal neovascular membranes complicating contusional eye injuries with indirect choroidal ruptures. Br J Ophthalmol 1990;74:93-6.
23. Secretan M, Sickenberg M, Zografos L, et al. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina 1998;18:62-6.
24. Zahlava J, Karel I, Lestak J. Best's vitelliform dystrophy with complications of a neovascular membrane and hemorrhage. Cesk Slov Oftalmol 2002;58:158-64.
25. Jain K, Shafiq AE, Devenyi RG. Surgical outcome for removal of subfoveal choroidal neovascular membranes in children. Retina 2002;22:412-17.
26. Sears J, Capone A Jr, Aaberg T Sr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology 1999;106:920-4.
27. Klein R, Lewis RA, Meyers SM, et al. Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 1978;96:2054-7.
28. Endo K, Yuzawa M, Ohba N. Choroideremia associated with subretinal neovascular membrane. Acta Ophthalmol Scand 2000;78:483-6.
29. Robinson D, Tiedeman J. Choroideremia associated with a subretinal neovascular membrane. Retina 1987;7:70-4.
30. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina 1992;12:127-33.
31. Ohno-Matsui K, Yoshida T, Futagami S, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003;87:570-3.
32. Avila MP, El-Markabi H, Azzolini C, et al. Bilateral choroidal osteoma with subretinal neovascularization. Ann Ophthalmol 1984;16:381-5.
33. Tsuchihashi T, Murayama K, Saito T, et al. Midperipheral mottling pigmentation with familial choroidal osteoma. Retina 2005;25:63-8.
34. Inoue M, Noda K, Ishida S, et al. Successful treatment of subfoveal choroidal neovascularization associated with combined hamartoma of the retina and retinal pigment epithelium. Am J Ophthalmol 2004;138:155-6.
35. Derosa JT, Yannuzzi LA. Marmor M, et al. Risk factors for choroidal neovascularization in young patients: a case-control study. Doc Ophthalmol 1995-96;91:207-22.
36. Goshorn EB, Hoover DL, Eller AW, et al. Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus 1995;32:178-82.
37. Wise GN, Henkind P, Alterman M. Optic disc drusen and subretinal hemorrhage. Trans Am Acad Ophthalmol Otolaryngol 1974;78:OP212-19.
38. Harris MJ, Fine SL, Owens SL. Hemorrhagic complications of optic nerve drusen. Am J Ophthalmol 1981;92:70-6.
39. Lindblom B, Andersson T. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology 1998;105:1816-20.
40. Farah ME, Costa RA, Muccioli C, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2002;134:137-9.
41. Giansanti F, Virgili G, Varano M, et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 2005;25:590-6.
42. Potter MJ, Szabo SM, Ho T. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol 2005;21:1-3.
43. Melberg NS, Thomas MA, Burgess DB. The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome. Retina 1996;16:190-5.
44. Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol 2000;118:1373-8.
45. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-76.
46. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000;106:829-38.
47. Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007;114:855-9.
48. Dafer RM, Schneck M, Friberg TR, et al. Intravitreal ranibizumab and bevacizumab: a review of risk. Semin Ophthalmol 2007;22:201-4.
49. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
50. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue: beyond blood vessels. Exp Neurol 2004;187:246-53.
51. Mateo C, Moreno JG, Lechuga M, et al. Surgical removal of peripapillary choroidal neovascularization associated with optic nerve drusen. Retina 2004;24:739-45.
52. Sullu Y, Yildiz L, Erkan D. Submacular surgery for choroidal neovascularization secondary to optic nerve drusen. Am J Ophthalmol 2003;136:367-70.
53. Mimouni KF, Bressler SB, Bressler NM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol 2003;135:900-2.
54. Oliveira LB, Reis PA. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol 2004;242:1028-30.
55. Silva R, Torrent T, Loureiro R, Travassos A, de Abreu JR. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin. Eur J Ophthalmol 2004;14:434-7.